Antibiotics
Catalog | Product Name / CAS / Description | Structure |
---|---|---|
BBF-03571 | ||
FR901469 is an antifungal antibiotic produced by fungal sp. No. 11243. It inhibits the activity of 1, 3-β-glucan synthase, and has strong anti-Candida albicans and Aspergillus fumigatus activity in vitro and in vivo. |
||
BBF-03572 | ||
FR901483 is originally isolated from Cladotryum sp. No. 11231. It has a strong immunosuppressive effect. |
||
BBF-03573 | ||
G-52 is originally isolated from Micromonospora zionesis. It has a wide antibacterial spectrum and is effective against the infection of Escherichia coli, Pseudomonas and Staphylococcus in mice. |
||
BBF-03574 | ||
It is an aminoglycoside antibiotic which has anti-gram-positive and anti-gram-negative activities. |
||
BBF-03575 | ||
It is produced by the strain of Cytophaga johnsonii. G 1499-2 can inhibit the growth of Flavobacterium, Staphylococcus aureus and Bacillus subtilis. |
||
BBF-03576 | ||
G2201-C is originally isolated from Streptomyces cattleya. It is resistant to Gram-positive bacteria and has a weak anti-Gram-negative activity. |
||
BBF-03577 | ||
GE 2270A is a thiopeptide antibiotic produced by the strain of Planobispora rosea. It inhibits bacterial protein synthesis and has anti-Gram-positive aerobic and anaerobic bacteria (MIC = 0.03-0.25 μg/mL) and Mycobacterium tuberculosis (MIC = 1 μg/mL) activities. |
||
BBF-03578 | ||
G7063-2 is produced by the strain of Streptomyces sp. It has anti-Gram-positive bacteria, negative bacteria and fungi activities. |
||
BBF-03581 | ||
It is originally isolated from Streptomyces sp. GERI-155. GERI-155 had anti-Gram-positive bacteria (MIC 0.09-12.5 μg/mL) and some Gram-negative bacteria, such as Pseudomonas aeruginosa and Salmonella typhimurium activities. |
||
BBF-03583 | ||
It is originally isolated from Streptomyces sp. GEX1. GEX1Q1 has no antibacterial activity but has cytotoxicity to some cancer cells. |
||
BBF-03584 | ||
It is originally isolated from Streptomyces sp. GEX1. GEX1Q2 has no antibacterial activity but has cytotoxicity to some cancer cells. |
||
BBF-03585 | ||
It is originally isolated from Streptomyces sp. GEX1. GEX1Q3 has no antibacterial activity but has cytotoxicity to some cancer cells. |
||
BBF-03586 | ||
A novel antifungal antibiotic GR 135402 has been isolated from a Graphium putredinis which inhibited protein synthesis in Candida albicans but not rabbit reticulocytes. |
||
BBF-03588 | ||
GTRI-BB is from Micromonospora sp. SA-246 with anti-gram-positive bacteria activity and cytotoxicity. The GI50 (μg/mL) of PC-3 (prostate), A549 (lung) and K562 (leukemia) cells were 0.21, 0.25 and 0.21 respectively. |
||
BBF-03589 | ||
IB-00208, a new cytotoxic polycyclic xanthone produced by Actinomadura sp. It also has anti-Gram-positive bacteria activity (MIC=0.09-1.4 nmol/L). |
||
BBF-03590 | ||
It is produced by the strain of Micromonospora L-25-ES25-008. Antibiotic IB 96212 had only antifungal activity against micrococcus luteus and particularly strong cytotoxicity against P388 with IC50 of 0.0001 μg/mL. |
||
BBF-03591 | ||
IC-202-A shows immunosuppressive activity, with IC50 of 3.6 μg/mL as determined by MLCR, and has a strong inhibitory effect on Blastogensis induced by ConA or lipopolysaccharide (LPS). |
||
BBF-03592 | ||
IC202B shows immunosuppressive activity, with IC50 of 3.6 μg/mL as determined by MLCR, and has a strong inhibitory effect on Blastogensis induced by ConA or lipopolysaccharide (LPS). |
||
BBF-03593 | ||
It is originally isolated from Cunninghamella sp. F-1490. ICM0201 can inhibit the formation of osteoclasts in mouse bone marrow cells with IC50 of 0.78 μg/mL. |
||
BBF-03594 | ||
IT-62-B is originally isolated from Streptomyces sp. IT-62. It had moderate anti-Gram-positive bacteria activity (MIC 6.25-12.5 μg/mL), and anti-L1210, P388, adriamycin-resistant P388 and KB tumor cells activity. |